Xenon Pharmaceuticals Inc. (XENE) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Xenon Pharmaceuticals (XENE) Q1 2026: $748M Raise Extends Runway, AZK Launch Momentum Accelerates
May 08, 2026
-
Xenon Pharmaceuticals (XENE) Q3 2025: XTOL2 Enrollment Exceeds Target With 380 Patients, Elevating Phase 3 Confidence
November 04, 2025
-
Xenon Pharmaceuticals (XENE) Q2 2025: XTOL2 Enrollment Completion Unlocks Phase 3 Epilepsy Data Visibility
August 11, 2025
-
Xenon Pharmaceuticals (XENE) Q1 2025: $691M Cash War Chest Extends Runway as Phase 3 Epilepsy Readout Nears
July 07, 2025